ONCOmmunity

DNA hypermethylation and 1p Loss silence NHE-1 in oligodendroglioma

By: Blough MD, Al-Najjar M, Chesnelong C, Binding CE, Rogers AD, Luchman HA, Kelly JJ, Fliegel L, Morozova O, Yip S, Marra M, Weiss S, Chan JA, Cairncross JG.

Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
Ann Neurol. 2012 Jun; 71(6):845-9. doi: 10.1002/ana.23610.

Abstract

Oligodendroglioma is characterized by mutations of IDH and CIC, 1p/19q loss, and slow growth. We found that NHE-1 on 1p is silenced in oligodendrogliomas secondary to IDH-associated hypermethylation and 1p allelic loss. Silencing lowers intracellular pH and attenuates acid load recovery in oligodendroglioma cells. Others have shown that rapid tumor growth cannot occur without NHE-1-mediated neutralization of the acidosis generated by the Warburg glycolytic shift. Our findings show for the first time that the pH regulator NHE-1 can be silenced in a human cancer and also suggest that pH deregulation may contribute to the distinctive biology of human oligodendroglioma.

PMID: 22718548 [PubMed - indexed for MEDLINE] Source: National Library of Medicine.